RecruitingNot ApplicableNCT06219252

Intraoperative Aberrometry vs Conventional Intraocular Lens Calculation, a Prospective Study.

Intraoperative Aberrometry vs Conventional Introcular Lens Calculation ( Barrett Universal II / Barrett True K ), Refractive and Visual Outcomes, a Prospective Study.


Sponsor

Instituto de Oftalmología Fundación Conde de Valenciana

Enrollment

300 participants

Start Date

Nov 3, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

the goal of this intervention study is to compare prospectively the accuracy of the power calculation between both groups, the intraoperative aberrometry (ORA) vs barrett universal II preoperative calculation (control group) . Researchers will compare ORA group vs control to see changes in spherical equivalent and uncorrected distance visual acuity


Eligibility

Min Age: 40 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Intraoperative aberrometer and Preoperative intraocular lens calculation for people with cataract, humans, and other related conditions. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEIntraoperative aberrometer

the patient intraocular lens will be optimized during the aphakic period after cataract extraction and before intraocular lens implantation, this will produce a possible change in the dioptric power of the intraocular lens

OTHERPreoperative intraocular lens calculation

the intraocular lens in this group will be calculated preoperatively with Barrett Universal II formula


Locations(1)

Instituto de oftalmología Fundación Conde de Valenciana

Mexico City, Cuauhtemoc, Mexico

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06219252


Related Trials